Stem cell-derived pancreatic islets are being studied as a rich transplantable source for insulin production, a therapeutic ...

A Beachwood-based biotechnology company has secured $20 million in financing that will enable an expansion in personnel, ...

Developed at the Children's Hospital of Philadelphia (CHOP) and called Zynteglo, the medicine uses the patient's own stem ...

Updated clinical and preclinical data showcase iPSC-derived off-the-shelf CAR T-cell therapy products for conditioning ...

April 29, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment ...

The potential of big data analytics (BDA) to transform the prevention, diagnosis, and treatment of cardiovascular diseases ...

Apr. 25, 2025 — Chimpanzee naive pluripotent stem cells (PSCs) can now be grown in cellular cultures, reveals a recent study. They successfully created chimpanzee early embryo models ...

Cambridge, Massachusetts– (Newsfile Corp. – May 8, 2025) – Ernexa Therapeutics (NASDAQ: ERNA), today announced its ...

Ernexa Therapeutics (Nasdaq: ERNA) is developing innovative cell therapies for the treatment of advanced solid tumors and autoimmune disease. Ernexa's core technology focuses on engineering induced ...